Temperature Controlled Packaging Solutions for Pharmaceuticals Market Size, Share & Growth Report for 2018 to 2028

The global temperature-controlled packaging solutions for pharmaceuticals market experienced substantial growth in 2018, reaching a size of nearly US$3.5 billion. This market is projected to continue expanding at a compound annual growth rate (CAGR) of 7.8% during the forecast period from 2018 to 2028.

One of the key factors driving this growth is the challenge of reaching patients residing in remote locations. To ensure the efficacy and safety of pharmaceutical products, it is crucial to maintain the appropriate temperature throughout the supply chain, especially in regions with limited access to healthcare facilities.

North America is expected to remain the largest regional market for temperature-controlled packaging solutions for pharmaceuticals. This can be attributed to the presence of large manufacturers and the high utilization of temperature-controlled pharmaceutical products in countries like the United States and Canada.

However, the Asia Pacific excluding Japan (APEJ) region shows significant growth potential. Factors such as the rapid increase in the prevalence of chronic diseases, a rising number of clinical trials in countries like China and India, and a growing demand for temperature-sensitive products contribute to the expansion of the market in this region.

Get 20% Discount @ https://www.futuremarketinsights.com/request-discount/rep-gb-5076

The temperature-controlled packaging solutions for pharmaceuticals market is anticipated to exceed the average growth rate during the forecast period. The key end-use industries for these solutions include healthcare, biomedical, and chemical industries.

Manufacturers are focusing on improving the quality of perishable pharmaceutical products to meet the increasing demand for a conducive environment. Additionally, the intervention of central healthcare bodies, such as the U.S. Food and Drug Administration (FDA), plays a significant role in driving the growth of this market. Regulatory requirements, like FDA regulations on proper temperature control during pharmaceutical distribution, prompt companies to adopt electronic temperature and humidity equipment for accurate delivery and dispatch of drugs.

Furthermore, the outbreak of the pandemic has further boosted the demand for temperature-controlled packaging solutions for pharmaceuticals. With a high dependency on healthcare and pharmaceutical products, the market witnessed increased demand during this period. Moreover, the use of temperature-controlled packaging solutions for vaccines and medicines aimed at treating and preventing COVID-19 is expected to contribute to market growth in the coming years.

Key takeaways:

• The global market for temperature-controlled packaging solutions for pharmaceuticals reached nearly US$3.5 billion in 2018 and is projected to grow at a CAGR of 7.8% during 2018-2028.
• Reaching patients in remote locations drives the demand for temperature-controlled packaging solutions for pharmaceuticals.
• North America is the largest regional market, while the Asia Pacific excluding Japan (APEJ) region shows high growth potential.
• The healthcare, biomedical, and chemical industries are the key end-use sectors for these solutions.
• Compliance with regulatory requirements, such as FDA regulations, and the intervention of central healthcare bodies drive market growth.
• The COVID-19 pandemic has further increased the demand for temperature-controlled packaging solutions, particularly for vaccines and medicines.